Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Postoperative Recovery
NCT06332157Not yet recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Sep 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of remimazolam in general anesthesia (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: 15-item quality of recovery scale. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06332157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06332157.